Jae-kyung Myung

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

ASH2L induces tamoxifen resistance via H3K4me3 dependent ITGA6/ERK signaling in ER-positive breast cancer.

ASH2L induces tamoxifen resistance via H3K4me3 dependent ITGA6/ERK signaling in ER-positive breast cancer.

Journal: British journal of cancer
Published: July 22, 2025

Correction: Park et al. ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells 2023, 12, 274.

Correction: Park et al. ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway. Cells 2023, 12, 274.

Journal: Cells
Published: September 19, 2024

CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer.

CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer.

Journal: Cancers
Published: January 16, 2023

ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway.

ABCA1-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway.

Journal: Cells
Published: December 07, 2022

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression.

Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression.

Journal: Biomedicines
Published: November 15, 2021

Characterization of Proteins Regulated by Androgen and Protein Kinase a Signaling in VCaP Prostate Cancer Cells.

Characterization of Proteins Regulated by Androgen and Protein Kinase a Signaling in VCaP Prostate Cancer Cells.

Journal: Biomedicines
Published: August 30, 2021

The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.

The Role of Nuclear Receptor Subfamily 1 Group H Member 4 (NR1H4) in Colon Cancer Cell Survival through the Regulation of c-Myc Stability.

Journal: Molecules and cells
Published: February 06, 2020

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.

Journal: PloS one
Published: November 09, 2016

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

Journal: The Journal of clinical investigation
Published: August 17, 2012

Large scale phosphoproteome analysis of LNCaP human prostate cancer cells.

Large scale phosphoproteome analysis of LNCaP human prostate cancer cells.

Journal: Molecular bioSystems
Published: June 16, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026